Nautilus Biotechnology Inc (NAUT)
2.68
+0.11
(+4.28%)
USD |
NASDAQ |
Nov 05, 11:46
Nautilus Biotechnology Market Cap: 336.51M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 322.70M |
| November 01, 2024 | 327.72M |
| October 31, 2024 | 326.47M |
| October 30, 2024 | 332.74M |
| October 29, 2024 | 347.81M |
| October 28, 2024 | 352.83M |
| October 25, 2024 | 337.77M |
| October 24, 2024 | 341.53M |
| October 23, 2024 | 345.29M |
| October 22, 2024 | 349.06M |
| October 21, 2024 | 347.80M |
| October 18, 2024 | 370.40M |
| October 17, 2024 | 360.36M |
| October 16, 2024 | 371.66M |
| October 15, 2024 | 356.59M |
| October 14, 2024 | 354.08M |
| October 11, 2024 | 359.10M |
| October 10, 2024 | 340.27M |
| October 09, 2024 | 350.31M |
| October 08, 2024 | 337.76M |
| October 07, 2024 | 333.99M |
| October 04, 2024 | 340.27M |
| October 03, 2024 | 330.22M |
| October 02, 2024 | 342.78M |
| October 01, 2024 | 339.01M |
| Date | Value |
|---|---|
| September 30, 2024 | 357.85M |
| September 27, 2024 | 364.95M |
| September 26, 2024 | 357.42M |
| September 25, 2024 | 353.66M |
| September 24, 2024 | 378.74M |
| September 23, 2024 | 349.27M |
| September 20, 2024 | 386.27M |
| September 19, 2024 | 376.23M |
| September 18, 2024 | 359.93M |
| September 17, 2024 | 364.32M |
| September 16, 2024 | 371.22M |
| September 13, 2024 | 363.69M |
| September 12, 2024 | 342.37M |
| September 11, 2024 | 344.88M |
| September 10, 2024 | 353.66M |
| September 09, 2024 | 333.59M |
| September 06, 2024 | 319.80M |
| September 05, 2024 | 322.31M |
| September 04, 2024 | 311.02M |
| September 03, 2024 | 318.54M |
| August 30, 2024 | 326.07M |
| August 29, 2024 | 323.56M |
| August 28, 2024 | 328.58M |
| August 27, 2024 | 331.09M |
| August 26, 2024 | 331.09M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
193.32M
Minimum
Dec 16 2022
1.364B
Maximum
Jun 10 2021
441.08M
Average
359.31M
Median
Market Cap Benchmarks
| Incyte Corp | 14.83B |
| Merck & Co Inc | 256.90B |
| Neogen Corp | 3.192B |
| Pfizer Inc | 157.39B |
| Repligen Corp | 8.010B |
Market Cap Related Metrics
| Price to Book Value | 1.506 |
| Price | 2.68 |
| Earnings Yield | -20.90% |